SMTI - sanaramedtech.com Debt to Book Capitalization Ratio

This SMTI (SMTI) trading chart demonstrates the price action of an asset whose logistics rely on strict temperature control for the transport of biological preparations. Sanara MedTech Inc. generates revenue from high-margin tissue regeneration matrices, utilizing an asset-light business model. The current indicator is 6.00. The business is completely insulated from external shocks, as it operates exclusively within the US domestic market.

SMTI (Sanara MedTech) Debt to Book Value history from 07/04/2022 to 10/28/2026

sanaramedtech.com (SMTI) - metric breakdowns and financial figures

- price and consensus price forecast:

Stock Price Sanara MedTech|SMTI - Analyst Consensus Forecast

- market capitalization data:

Market Value Sanara MedTech Inc.|SMTI - Value Adjusted for Debt and Cash

- book capitalization data:

Net Assets per Single Share Sanara MedTech|SMTI - Company Net Assets|Market Capitalization to Book Value Ratio sanaramedtech.com|SMTI - Company Total Assets

- debt and liquidity data:

Total Debt to Equity Ratio Sanara MedTech Inc.|SMTI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Sanara MedTech|SMTI - Company Total Debt Obligations|Debt to Book Capitalization Ratio Sanara MedTech Inc.|SMTI - Company Long-Term Debts|Company Short-Term Debts Sanara MedTech

Summary company analytics:Sanara SMTI

Steady demand for surgical materials from Sanara MedTech Inc. (SMTI) allows for an assessment of business resilience through the debt-to-capitalization ratio. This metric correlates total debt with the book value of assets, identifying the risk of capital degradation during periods of market shocks and helping investors determine the acceptable level of leverage to protect their investments.

Competitors of Sanara MedTech Inc.